Navigation Links
Inverseon Announces Positive Phase IIa Asthma Study
Date:1/29/2008

SAN FRANCISCO, Jan. 29 /PRNewswire/ -- Inverseon, Inc. (http://www.inverseon.com) announces the publication of a positive phase IIa clinical trial in asthma.

In the article by Hanania et al., in Pulmonary Pharmacology & Therapeutics, vol. 21, (2008), pp. 134-141, entitled, "The safety and effects of the beta-blocker, nadolol, in mild asthma: An open-label pilot study," mild asthmatics were treated for 9 weeks. All subjects tolerated the drug, and 8 of 10 subjects experienced a clinically meaningful, dose-related, reduction in airway hyper-responsiveness.

"To our knowledge, this is the first peer-reviewed publication of a clinical trial testing a beta-blocker for the treatment of asthma," commented Richard Bond, PhD, Scientific Founder of Inverseon. "These results lay the groundwork for continuing safety and efficacy studies for a drug that is normally withheld from asthmatics. A similar story played out 10 years ago in congestive heart failure where certain blocker drugs that were once contraindicated are now on the market as the best drugs we have ever had at decreasing mortality in heart failure."

"From receptor theory to animal data and now to clinical data the Inverseon approach is very consistent. In our animal asthma models chronic dosing of beta inverse agonists -- which are a subset of beta blockers -- resulted in up-regulation of lung beta receptors, while reducing inflammation and airway hyper-responsiveness. The fact that we are seeing some of these same changes in human asthmatic subjects is exciting and suggests we may have a way to counteract some of the negative aspects of long-acting beta-agonists and steroids when used in combination with INV102. The data also supports Inverseon's reformulation program for oral controlled-release INV102," commented William J. Garner, MD, Chairman of Inverseon.

About Inverseon, Inc.

Inverseon's product development programs
'/>"/>

SOURCE Inverseon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
2. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
3. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
4. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
5. InterCure Announces 100,000th RESPeRATE Unit Sold
6. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
7. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
8. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... blood instrumentation and consumables to the medical, research and ... Chairman and Chief Executive Officer, will present at the ... 2014 on Tuesday, September 9, 2014 at 12:30 p.m. ... Berkshire Place Hotel in New York City ...
(Date:8/29/2014)... , August 29, 2014 ... and collaboration software has announced a major new deal ... founded by renowned pathology expert, Dr. Marius Nap ... of the 26th European Congress of Pathology which is ... the ExCeL Arena, London where ...
(Date:8/29/2014)... ANDOVER, Mass. , Aug. ...  (NYSE: PHG ... at the  European Society of ... company is highlighting the full range of its cardiology solutions ... the care continuum from prevention and ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... Jan. 28, 2011 Drug safety remains front and ... the agency strives to improve the public,s perception of ... improving its reputation among consumers and recognizes that its ... important role in that effort. One issue ...
... Burg Simpson Eldredge Hersh & Jardine, P.C., one of the ... that shareholder, Seth. A. Katz, has been appointed by the ... the Plaintiffs, Steering Committee in the multidistrict litigation against DePuy Orthopaedics, ... Hip System. In August 2010, DePuy Orthopaedics, Inc., ...
Cached Medicine Technology:Navigating the Gray Areas of Post-Marketing Surveillance 2Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc. 2
(Date:8/30/2014)... One of the most recent dietary trends ... diet. Originally meant for sufferers of gluten intolerance and celiac ... who are looking to get healthier by simply consuming foods ... kind of information erroneous, it also exposes those same consumers ... a drastic change in their food consumption habits. ...
(Date:8/30/2014)... The new review published by Daily Gossip reveals that the ... wanted to make her guide accessible to sufferers from all ... to find in the form of an eBook, which is ... the new method shares all her tips and recommendations for ... review that the leaky gut syndrome can be an extremely ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 August 28th, ... shoulder pain in our society and the toll that ... costs, it’s vital that continuing education for physical therapists ... to help physical therapists help others, Hands-On Seminars is ... , Three learning styles are available to ...
(Date:8/30/2014)... Ms. Meriwether’s striking beauty is not all that ... impressive resume to boost. Nana is best known for ... she’s also a two time All American UCLA volleyball player ... the 2008 Olympics and played professional volleyball as well. ... from Potomac, Maryland is a two-time, All American athlete; she ...
(Date:8/30/2014)... 2014 When a prominent bank reveals a ... on Wednesday, August 27th, when news began surfacing about the ... & Co and at least one other bank. But ... investigating attacks on seven prominent banks , everyone starts thinking ... and the buzz quickly goes viral. Bloomberg followed up ...
Breaking Medicine News(10 mins):Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:NJ Top Dentists Announces Cover Model for the Healthy Living: Top Dentists Issue 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5
... 8 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. (OTC ... pharmaceutical, medicinal and diagnostic products in China,today announced ... to,the Company,s Form 10KSB for the year 2006. ... Form 10QSB for the three, six and nine ...
... COMPANY REPORTS PROGRESS ON KEY INITIATIVES, RANCHO CORDOVA, ... a leading supplier of innovative products and,services that process, ... treatment of disease and injury, today reported results for,the ... quarter ended September 30, 2007, were $3.6 million,compared with ...
... OWINGS MILLS, Md., Nov. 8 Medifast, Inc.,(NYSE: ... the period ended,September 30, 2007. For quarter-ended September 30, ... from $19.6 million in the third,quarter of 2006. The ... share ($0.07 per diluted share), versus $1,455,000 or $0.11 ...
... ESAs can increase cancer growth, cause stroke and heart ... News) -- The U.S. Food and Drug Administration on ... erythropoiesis-stimulating agents, which are drugs used to treat certain ... Aranesp, Epogen and Procrit, and detail their dangers to ...
... N.J., Nov. 8 Wyeth (NYSE: WYE ),announced ... First Boston,Healthcare Conference on Tuesday, November 13, 2007 at ... M. Mahady, Senior Vice President,Wyeth and President, Wyeth Pharmaceuticals ... for investors at, http://www.wyeth.com and available for replay ...
... CLEVELAND, Nov. 8 Medical Mutual and Ohio ... to provide quality,affordable health insurance to OFBF,s more ... Farm Bureau members will gain access to,Medical Mutual,s ... hospitals and other medical service providers in Ohio. ...
Cached Medicine News:Health News:China Sky One Medical Completes Previously Announced Amendment to 2006 Form 10KSB 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 3Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 4Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 5Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 6Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 2Health News:Medifast Announces Third-Quarter 2007 Results 3Health News:Medifast Announces Third-Quarter 2007 Results 4Health News:Medifast Announces Third-Quarter 2007 Results 5Health News:Medifast Announces Third-Quarter 2007 Results 6Health News:Medifast Announces Third-Quarter 2007 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 8Health News:FDA Issues New Warnings for Anemia Drugs 2Health News:FDA Issues New Warnings for Anemia Drugs 3Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 2Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 3
... contains primers and a FAM-labeled probe that ... gene. In addition, this ASR contains primers, ... internal control sequence. This ASR requires an ... Red reporter dyes such as the Cepheid ...
...
Reptilase-Time from Bothrops atrox...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Medicine Products: